Worst‑Case Device: Definition, Use in Testing, and Impact on Re‑Validation

What is a Worst‑Case Device?

A worst‑case device (also referred to as representative sample, representative configuration, or worst‑case configuration) is the version of a device that is expected to challenge the design the most during verification and validation. It represents the configuration most likely to fail if the design were insufficient.

Regulators require worst‑case justification to ensure that testing covers the full device family without testing every variant.

Worst‑Case Device Selection During Testing

Testing all models in a device family is usually impractical. Laboratories therefore select a worst‑case configuration based on design parameters that influence safety and performance. Selection may be based on the manufacturer’s device family or on a third‑party worst‑case model, depending on the test type.

Factors commonly used to determine worst‑case:

Lumens, cannulations, and internal pathways

Hinges, joints, and mated surfaces

Small or fragile internal components

Surface roughness, coatings, and material treatments

Packaging configuration and thermal mass

Typical worst‑case dimensions:

Largest or smallest size for mechanical stress and fatigue

Highest energy output for electrical safety and EMC

Longest patient contact duration for biocompatibility

Highest drug concentration for combination products

Most complex software configuration for software validation

Most challenging sterilization load for sterility assurance

Most demanding packaging configuration for transport simulation

A clear rationale must link each selected configuration to the risk it represents.

Evaluation Based on Worst‑Case Testing

After testing, manufacturers typically prepare an evaluation report or summary of testing. This document explains how the worst‑case results apply to the entire product family.

The evaluation should:

Summarise test results

Demonstrate equivalence across all variants

Justify why the selected configuration represents the worst‑case

Link worst‑case logic to risk management and design inputs

This approach is similar to the sampling concept used by Notified Bodies when reviewing technical documentation in EU: a representative sample stands in for the full family.

A dedicated chapter should describe the worst‑case analysis and identify design parameters that will remain relevant throughout the device’s lifecycle, including future change assessments.

Impact of Design Changes

Manufacturers must update testing and evaluation when changes occur in:

Product design

Manufacturing processes

Raw materials (including packaging)

Usage scenarios

Sterilization or packaging methods

Critical manufacturing processes

Transport or storage conditions

Applicable standards or regulatory requirements

When Is Re‑Validation Required?

Factors that typically trigger re‑validation:

Changes affecting critical physical or chemical parameters

Changes to critical components

Changes in raw materials

Modifications to intended use or use scenarios

Changes in sterilization method or packaging system

Significant process changes in manufacturing

Re‑validation is required when existing evidence no longer adequately supports safety and performance. This may include:

Delta testing

For minor or moderate changes, delta testing can demonstrate that the modified device remains equivalent to the previously validated configuration. This approach is common in markets like the US, where demonstrating equivalence through targeted testing is often acceptable.

Full re‑validation

Full re‑validation is needed when:

Multiple significant changes accumulate

The worst‑case configuration shifts

Intended use changes

Sterilization or biocompatibility profiles change

Standards or regulatory requirements are revised

Passive triggers

Country‑specific regulatory requirements

Revisions of harmonised standards or guidance documents

Best practice